CIK 0001856725 · <br>Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 863114789
- Phone
- (408) 457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-27 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −7,906 | $1.40 | $11K | 460,678 |
| 2025-10-23 | Bailey Vasudev Jaiprakash Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-10-23 | Bassan Abraham Director | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-10-23 | IMRAN MIR A Director | Purchase | +2,083,334 | $0.61 | $1.3M | 2,083,334 |
| 2025-10-23 | IMRAN MIR A Director | Purchase · Warrant to Purchase Class A Common Stock | +2,083,334 | 2,083,334 | ||
| 2025-10-21 | South Cone Investments Limited Partnership 10% owner | Sale | −4,000,000 | $2.77 | $11.1M | 2,379,194 |
| 2025-10-20 | South Cone Investments Limited Partnership 10% owner | Sale | −1,923,000 | $2.41 | $4.6M | 6,379,194 |
| 2025-09-27 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −9,077 | $0.48 | $4K | 468,584 |
| 2025-08-01 | McKinley Kate Chief Business Officer | Grant or award · Employee Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2025-06-27 | Imran Talat Chief Executive Officer | Shares withheld for taxes | −9,076 | $0.55 | $5K | 477,661 |
| 2025-05-28 | Nanavaty Maulik Director | Grant or award · Director Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-28 | IMRAN MIR A Director | Grant or award · Director Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-28 | Rometty Lisa Ann Director | Grant or award · Director Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-28 | BUTEL JEAN LUC Director | Grant or award · Director Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-28 | Ausiello Dennis A Director | Grant or award · Director Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-28 | Farquharson Andrew Director | Grant or award · Director Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2025-05-23 | Hashim Mir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2025-05-23 | McKinley Kate Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2025-05-23 | Sanford Svai S Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2025-05-23 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,053,000 | 1,053,000 |
Page 2 of 9 · 178 trades